May 7, 2026 05:13PM
May 5, 2026 04:00PM
Mar 30, 2026 04:00PM
Mar 11, 2026 06:05AM
Feb 19, 2026 12:16PM
Feb 12, 2026 07:01AM
Feb 10, 2026 08:04AM INmune Bio submits CORDStrom pre-application to UK regulators for RDEB
Jan 27, 2026 09:25AM
Oct 30, 2025 04:23PM
Aug 7, 2025 05:44PM
Aug 4, 2025 12:13PM
Aug 4, 2025 08:14AM
Jun 30, 2025 04:37PM
Jun 30, 2025 04:01PM Lucid Capital Markets Downgrades INmune Bio Inc. (INMB) to Neutral
Jun 30, 2025 02:24PM
Jun 30, 2025 01:49PM
Jun 30, 2025 10:36AM
Jun 30, 2025 07:30AM
Jun 27, 2025 12:16PM
Jun 26, 2025 04:42PM
Jun 26, 2025 04:01PM INmune Bio (INMB) to Announce Top Line Results from MINDFuL Phase 2 Trial in Early Alzheimer’s on Monday, June 30th
Jun 24, 2025 10:47AM
Jun 23, 2025 10:53AM
Jun 10, 2025 04:02PM
Jun 4, 2025 06:18AM
May 8, 2025 04:14PM
Apr 16, 2025 07:01AM
Apr 1, 2025 07:02AM INmune Bio (INMB) Presents Baseline Demographics and Disease Profiles of Participants in the MINDFuL Phase II Study
Mar 31, 2025 04:54AM
Feb 12, 2025 07:03AM
Feb 12, 2025 05:12AM
Feb 11, 2025 06:53AM
Feb 10, 2025 07:03AM
Jan 28, 2025 10:26AM
Jan 28, 2025 08:05AM INmune Bio (INMB) Expands INKmune Trial in Prostate Cancer to Veterans
Jan 28, 2025 06:31AM
Oct 31, 2024 04:12PM
Sep 26, 2024 08:01AM
Sep 18, 2024 09:14AM
Sep 18, 2024 06:22AM
Sep 17, 2024 08:31AM
Sep 13, 2024 08:31AM INmune Bio (INMB) Prices 2.34M Share Offering at $5.50/sh
Aug 22, 2024 07:38AM
Aug 2, 2024 04:03PM
Aug 1, 2024 04:51PM
Jul 29, 2024 09:00AM
Jul 23, 2024 08:45AM

412,728 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All